Smoking and severe illness in hospitalized COVID-19 patients in Japan

Abstract Background The aim of this study was to identify associations between smoking status and the severity of COVID-19, using a large-scale data registry of hospitalized COVID-19 patients in Japan (COVIREGI-JP), and to explore the reasons for the inconsistent results previously reported on this...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of epidemiology Vol. 51; no. 4; pp. 1078 - 1087
Main Authors Matsushita, Yumi, Yokoyama, Tetsuji, Hayakawa, Kayoko, Matsunaga, Nobuaki, Ohtsu, Hiroshi, Saito, Sho, Terada, Mari, Suzuki, Setsuko, Morioka, Shinichiro, Kutsuna, Satoshi, Mizoue, Tetsuya, Hara, Hisao, Kimura, Akio, Ohmagari, Norio
Format Journal Article
LanguageEnglish
Published England Oxford University Press 10.08.2022
Subjects
Online AccessGet full text
ISSN0300-5771
1464-3685
1464-3685
DOI10.1093/ije/dyab254

Cover

More Information
Summary:Abstract Background The aim of this study was to identify associations between smoking status and the severity of COVID-19, using a large-scale data registry of hospitalized COVID-19 patients in Japan (COVIREGI-JP), and to explore the reasons for the inconsistent results previously reported on this subject. Methods The analysis included 17 666 COVID-19 inpatients aged 20–89 years (10 250 men and 7416 women). We graded the severity of COVID-19 (grades 0 to 5) according to the most intensive treatment required during hospitalization. The smoking status of severe grades 3/4/5 (invasive mechanical ventilation/extracorporeal membrane oxygenation/death) and separately of grade 5 (death) were compared with that of grade 0 (no oxygen, reference group) using multiple logistic regression. Results were expressed as odds ratios (OR) and 95% confidence intervals (CI) adjusted for age and other factors considering the potential intermediate effects of comorbidities. Results Among men, former smoking significantly increased the risk of grade 3/4/5 and grade 5, using grade 0 as a reference group, with age- and admission-date-adjusted ORs (95% CI) of 1.51 (1.18–1.93) and 1.65 (1.22–2.24), respectively. An additional adjustment for comorbidities weakened the ORs. Similar results were seen for women. Current smoking did not significantly increase the risk of grade 3/4/5 and grade 5 in either sex. Conclusions The severity of COVID-19 was not associated with current or former smoking per se but with the comorbidities caused by smoking. Thus, smoking cessation is likely to be a key factor for preventing smoking-related disease and hence for reducing the risk of severe COVID-19.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0300-5771
1464-3685
1464-3685
DOI:10.1093/ije/dyab254